Nile Pharma’s profits jump 32.7% YoY in FY 2022/23: Egypt

Getty Images

Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions

Staff Writer, Arab Finance

August 16, 2023

PHOTO

El Nile Company for Pharmaceuticals and Chemical Industries (Nile Pharma) (NIPH) reported a 39.19% year-on-year (YoY) increase in net profits for fiscal year (FY) 2022/2023, according to the financial income statement filed to the Egyptian Exchange (EGX) on August 15th.

Net profits amounted to EGP 118.965 million in FY 2022/2023, compared to EGP 89.672 million in the FY before.

Operating revenues climbed 15.5% YoY to EGP 1.012 billion in the FY ended June 30th, 2023, compared to EGP 876.780 million in FY 2021/2022.

Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.